An open label, randomised study investigating efficacy and safety of Vonoprazan in triple therapy for eradication of Helicobacter pylori infection

Trial Profile

An open label, randomised study investigating efficacy and safety of Vonoprazan in triple therapy for eradication of Helicobacter pylori infection

Recruiting
Phase of Trial: Phase II

Latest Information Update: 15 Dec 2016

At a glance

  • Drugs Vonoprazan (Primary) ; Amoxicillin; Clarithromycin; Esomeprazole
  • Indications Helicobacter infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Dec 2016 New trial record
    • 19 Oct 2016 Interim results (n=100) presented at the 24th United European Gastroenterology Week.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top